Highest R&D Intensity

Name: Highest R&D Intensity Dataset
Creator: Billiver
License: https://www.sec.gov/privacy#publicinfo

Companies ranked by R&D spending as a percentage of revenue, indicating focus on innovation and future growth. Top 50 S&P 500 companies ranked by r&d intensity.

Companies

39.9%

Highest

32.2%

Median

32.5%

Average

Top 50 by R&D Intensity

#	Company	Sector	R&D Intensity
1	INCYIncyte	Health Care	39.9%
2	OUSTOuster, Inc.	Industrials	38.5%
3	BFLYButterfly Network, Inc.	Health Care	37.1%
4	TXG10x Genomics, Inc.	Health Care	37.1%
5	GHGuardant Health, Inc.	Health Care	37.1%
6	HTFLHeartflow, Inc.	Health Care	36.9%
7	FROGJFrog Ltd	Information Technology	36.7%
8	SITMSiTime	Information Technology	36.4%
9	LSCCLattice Semiconductor	Information Technology	35.9%
10	MIRMMirum Pharmaceuticals, Inc.	Health Care	35.7%
11	ALABAstera Labs, Inc.	Information Technology	35.7%
12	EXELExelixis	Health Care	35.6%
13	RDDTReddit, Inc.	Information Technology	35.6%
14	ALNYALNYLAM PHARMACEUTICALS, INC.	Health Care	35.5%
15	NBIXNeurocrine Biosciences	Health Care	35.5%
16	SNPSSynopsys	Information Technology	35.1%
17	TBPHTheravance Biopharma, Inc.	Health Care	34.8%
18	BBNXBeta Bionics, Inc.	Health Care	34.7%
19	PLPlanet Labs PBC	Information Technology	34.7%
20	NVCRNovoCure Ltd	Health Care	34.3%
21	ADPTAdaptive Biotechnologies Corp	Health Care	33.9%
22	PINSPinterest	-	33.8%
23	CORTCorcept Therapeutics Incorporated	Health Care	33.5%
24	VRTXVertex Pharmaceuticals	Health Care	32.6%
25	SSentinelOne, Inc.	Information Technology	32.3%
26	IRWDIRONWOOD PHARMACEUTICALS INC	Health Care	32.1%
27	RBLXRoblox Corp	Information Technology	32.1%
28	TTANServiceTitan, Inc.	Information Technology	31.5%
29	RIVNRivian Automotive, Inc. / DE	Consumer Discretionary	31.0%
30	ACADAcadia Pharmaceuticals	Health Care	30.7%
31	NVAXNOVAVAX INC	Health Care	30.5%
32	LGNDLigand Pharmaceuticals, Inc.	Health Care	30.3%
33	SNAPSnap Inc	Information Technology	30.2%
34	GKOSGlaukos Corp.	Health Care	29.7%
35	DUOLDuolingo	Consumer Discretionary	29.5%
36	APLSApellis Pharmaceuticals, Inc.	Health Care	29.5%
37	MDBMongoDB, Inc.	Information Technology	29.1%
38	DBXDropbox	Information Technology	29.0%
39	NTNXNutanix	Information Technology	29.0%
40	HUBSHUBSPOT INC	Information Technology	28.9%
41	GTLBGitlab Inc.	Information Technology	28.7%
42	AXSMAxsome Therapeutics, Inc.	Health Care	28.7%
43	BMRNBioMarin Pharmaceutical	Health Care	28.6%
44	METAMeta Platforms	Communication Services	28.5%
45	AMPLAmplitude, Inc.	Information Technology	28.4%
46	PIImpinj, Inc.	Information Technology	28.4%
47	RBRKRubrik, Inc.	Information Technology	28.4%
48	SYKStryker Corporation	Health Care	27.7%
49	PCORPROCORE TECHNOLOGIES, INC.	Information Technology	27.4%
50	INTAIntapp, Inc.	Information Technology	27.3%

Understanding R&D Intensity

R&D intensity measures how much a company invests in research and development relative to its revenue. Higher R&D intensity often indicates a focus on innovation and long-term competitive advantage. Tech companies like Intel and Qualcomm typically have 15-25% R&D intensity, while pharmaceutical companies invest 10-20%.

R&D Intensity = R&D Expense / Revenue

Data Quality Note

Rankings are based on SEC EDGAR filings. Companies with missing, unreliable, or extreme outlier values are excluded from this ranking.

Related Rankings

By Sector

Highest R&D Intensity in Communication Services Highest R&D Intensity in Consumer Discretionary Highest R&D Intensity in Consumer Staples Highest R&D Intensity in Energy

Global Rankings

Largest Companies by Revenue Most Profitable Companies Highest Profit Margin Highest Return on Equity Highest Return on Assets Lowest Debt-to-Equity Ratio

For informational purposes only. Not investment advice. Data may be delayed or inaccurate; verify independently. About · Methodology The information on this page is for informational purposes only and does not constitute investment advice, financial advice, or any recommendation. Billiver does not recommend buying, selling, or holding any security. Past performance is not indicative of future results. Data may be delayed and accuracy is not guaranteed. All investment decisions are solely your responsibility. Verify information independently and consult a qualified financial advisor before investing.